FINECARE
LIVE

Serial Number

79194964

Owner

GUANGZHOU WONDFO BIOTECH CO., LTD

Attorney

Joe McKinney Muncy

Filing Date

Jul 18, 2016

Add to watchlist:

No watchlists yet
View on USPTO

FINECARE Trademark

Serial Number: 79194964 • Registration: 5288241

FINECARE is a trademark filed by GUANGZHOU WONDFO BIOTECH CO., LTD on July 18, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

GUANGZHOU WONDFO BIOTECH CO., LTD (14 trademarks)

No. 8 Lizhishan Road,

Entity Type: 99

Trademark Details

Filing Date

July 18, 2016

Registration Date

September 19, 2017

Published for Opposition

July 4, 2017

Goods & Services

[ Pharmaceutical preparations for the treatment of diabetes and skin conditions; chemical preparations for medical purposes, namely, diagnosis of pregnancy; chemical preparations for sanitary purposes; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, diabetes and skin conditions; cultures of microorganisms for medical or veterinary use; biological preparations for medical purposes for the treatment of cancer, diabetes and skin conditions; chemical preparations for pharmaceutical purposes for the treatment of respiratory infections; chemical preparations for medical purposes for the treatment of immune system diseases; enzyme preparations for medical purposes; chemical preparations for the diagnosis of pregnancy; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes ]

[ Nursing appliances, namely, nursing bottles, breast pumps; blood testing apparatus; medical apparatus and instruments for use in treating cardiovascular disease; testing apparatus for medical purposes, namely, eye testing apparatus; ]immunochemical testing apparatus for medical use; [ organoleptic diagnostic testing apparatus for medical; apparatus for use in medical analysis for monitoring oxymetory, vital signs and blood properties; fumigation apparatus for medical purposes; medical apparatus, namely, spirometers; thermometers for medical purposes; diagnostic apparatus for medical purposes, namely, the ultrasonic medical diagnostic apparatus; ] medical diagnostic apparatus for detection of cancer, inflammation, neoplasm, infectious disease, sexually transmitted disease, diabetes, kidney diseases and narcotic drugs [ ; arterial blood pressure measuring apparatus ]

Filing History

PARTIAL INVALIDATION PROCESSED BY THE IB
Jan 4, 2025 INNP
GENERIC MADRID TRANSACTION SENT TO IB
Nov 24, 2024 XXSS
GENERIC MADRID TRANSACTION CREATED
Nov 24, 2024 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 6, 2024 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Mar 5, 2024 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Mar 5, 2024 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 4, 2024 APRE
TEAS SECTION 71 RECEIVED
Jun 26, 2023 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Jun 5, 2021 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jun 1, 2018 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 23, 2018 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Jan 7, 2018 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 6, 2018 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 19, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 19, 2017 R.PR
PUBLISHED FOR OPPOSITION
Jul 4, 2017 PUBO
NOTICE OF PUBLICATION
Jun 14, 2017 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 23, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 3, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 3, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 3, 2017 TROA
REFUSAL PROCESSED BY IB
Nov 25, 2016 RFNT
APPLICATION FILING RECEIPT MAILED
Nov 5, 2016 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 4, 2016 RFCS
REFUSAL PROCESSED BY MPU
Nov 4, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 3, 2016 RFCR
NON-FINAL ACTION WRITTEN
Nov 2, 2016 CNRT
ASSIGNED TO EXAMINER
Nov 2, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 1, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 27, 2016 REPR